Latest Breaking News On - ப்ரொஃபெஸர் ஈயந் ஃப்ரேசர் - Page 1 : comparemela.com

2021-04-16 11:35:50 GMT2021-04-16 19:35:50(Beijing Time) Xinhua English SYDNEY, April 16 (Xinhua) A Brisbane and Seattle-based company said on Friday that a new therapeutic candidate for the treatment of COVID-19 patients will enter a clinical trial in the United States, led by Professor Ian Frazer, a former recipient of the Australian of the Year award. Developed by biotechnology company Implicit Bioscience, the drug IC14 will be tested in more than 400 COVID-19 patients in 10 to 15 hospitals across the United States this week. Volunteer participants will be assigned at random to receive intravenous infusions of either IC14 or a placebo for four days.

United statesNew south walesIan frazerAnthonys fauciUs national institute of allergyProfessor ian frazerImplicit bioscienceProfessor frazerஒன்றுபட்டது மாநிலங்களில்புதியது தெற்கு வேல்ஸ்ஈயந் ஃப்ரேசர்எங்களுக்கு தேசிய நிறுவனம் ஆஃப் ஒவ்வாமைப்ரொஃபெஸர் ஈயந் ஃப்ரேசர்ப்ரொஃபெஸர் ஃப்ரேசர்